USPTO serial 79313377
OSTEOEDGE
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jul 5, 2022
- Examiner
- BELL, MARLENE D
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with OSTEOEDGE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Matthew J. Stark
Matthew J. Stark Price Heneveld LLP695 Kenmoor Avenue SEGrand Rapids, MI 49501UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Stem cells for medical purposes; collagen for medical use; biodegradable implants being living cells or implantable scaffolds comprising biological materials for use in guided tissue regeneration; surgical implant materials being living cells or implantable scaffolds comprising biological materials for use in guided tissue regeneration; implantable materials being living cells or implantable scaffolds comprising biological materials for use in guided tissue regeneration; implants being living cells or implantable scaffolds comprising biological materials for use in guided tissue regeneration; surgical implants comprised of living tissues; medical therapeutic agents for tissue regeneration; medical therapeutic biological products, namely, biological cell cultures for medical purposes; medical preparations, namely, medical preparations for tissue regeneration; guided tissue regeneration materials, namely, materials for the regeneration of bone and soft tissue, namely, living tissue and nerve tissue; biological preparations for medical purposes for use in guided tissue regeneration for tissue repair; tissue-regenerative medical preparations for use in regeneration of damaged bone and soft tissue, namely, living tissue and nerve tissue; tissues for medical use being living cells; collagen based scaffolding for biomechanical support and stabilization, namely, implantable scaffolds comprising biological materials; cellular therapeutic tendon and cartilage regeneration products, namely, living cells or implantable scaffolds comprising biological materials | ACTIVE | — |
| 010 | Medical implants, namely, implants made from artificial biomaterials, namely, synthetic collagen, for use in the regeneration of bone and soft tissue, and nerve tissue; orthopaedic implants, namely, implants made from artificial biomaterials for use in the regeneration of bone and soft tissue, and nerve tissue; surgical implants comprised of artificial materials; dental implants made of artificial materials; biodegradable bone fixation implants made of artificial materials; surgical implants comprised of artificial materials for use in guided tissue regeneration; surgical implants comprised of artificial materials for replacing human tissue; surgical prostheses, namely, implantable scaffolds comprising artificial materials for the regeneration of bone and soft tissue and nerve tissue; artificial skin for surgical purposes; surgical prosthesis implants made of artificial materials for use in human medicine; orthopaedic materials, namely, orthopaedic materials made from artificial biomaterials for use in the regeneration of bone and soft tissue, and nerve tissue; artificial orthopaedic implants; artificial materials for use in guided tissue regeneration, namely, implantable scaffolds comprising artificial biomaterials for the regeneration of bone and soft tissue, and nerve tissue; artificial replacement materials for human tissue, namely, synthetic collagen based scaffolding materials; surgical implants comprised of artificial materials for replacing animal and human tissue | ACTIVE | — |
| 044 | Advisory services relating to medical services namely providing advice in the field of bone and soft tissue regeneration; medical services; medical advisory services; medical care services for the regeneration of bone and soft tissue; medical health assessment services; medical treatment services for the regeneration of bone and soft tissue; provision of medical information; provision of medical services; therapy services for the regeneration of bone and soft tissue; physical therapy; medical services, including those relating to biomechanical and cellular therapeutic medical techniques | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Orthocell Limited
- Other trademarks owned by Orthocell Limited
- Other trademarks owned by Orthocell Limited
- Other trademarks in Class 005
- Other trademarks in Class 010
- Other trademarks in Class 044
- Similar marks named OSTEOEDGE
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 7, 2022 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Oct 18, 2022 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Oct 18, 2022 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Oct 5, 2022 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jul 5, 2022 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Jul 5, 2022 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| May 3, 2022 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Apr 19, 2022 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Apr 19, 2022 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Apr 13, 2022 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Apr 13, 2022 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Mar 30, 2022 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Mar 12, 2022 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 11, 2022 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Mar 11, 2022 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Mar 11, 2022 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Mar 11, 2022 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Feb 18, 2022 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 18, 2022 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 18, 2022 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 5, 2021 | RFNT | REFUSAL PROCESSED BY IB | — |
| Oct 12, 2021 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Oct 12, 2021 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Sep 26, 2021 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Sep 25, 2021 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 19, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 26, 2021 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jun 22, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jun 17, 2021 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |